Product description
Rhodiola rosea has traditionally been wild-harvested, but its recent inclusion in the CITES Annex II list of endangered species has significantly disrupted its supply chain.
BOTALYS pioneers the cultivation of rare medicinal plants through Biomimetic Indoor Farming, ensuring sustainability without depleting wild populations. This innovative approach allows for the cultivation of plants that meet the highest standards of quality, purity, and environmental responsibility.
BOTALYS Fjord Rhodiola is derived from a proprietary Rhodiola rosea cultivar, grown under optimized conditions to achieve a standardized, full-spectrum molecular profile. With a naturally rich composition, it contains 3% salidroside, offering exceptional consistency and potency.
Read more